Evidence map›Paper›PMID 21362629›Full record

ArticleCarcinogenesis2011

Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors.

Kyungsil Yoon, Syng-Ook Lee, Sung-Dae Cho, Kyounghyun Kim, Shaheen Khan, Stephen Safe

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Bladder Exposure toFrontiers in cellular and infection microbiology · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Nurr1-Based Therapies for Parkinson's Disease.CNS neuroscience & therapeutics · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Kyungsil YoonInstitute of Bioscience and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
Syng-Ook Lee
Sung-Dae Cho
Kyounghyun Kim
Shaheen Khan
Stephen Safe
Texas A&M Health Science Center · USTexas A&M University · USJeonbuk National University · KR

Funding

NUR77 Agonists: New Targets for Pancreatic Cancer ChemotherapyR01CA124998 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SAFE, STEPHEN H. · 2007 to 2011
$1.1M
NCI NIH HHS R01 CA124998NCI NIH HHS R01CA124998
6 · The paper itself

Abstract

NR4A1 (Nur77, TR3) is overexpressed in pancreatic tumors and activation of TR3 by 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane (DIM-C-pPhOCH(3)) inhibits cell and tumor growth and induces apoptosis. Microarray analysis demonstrates that in L3.6pL pancreatic cancer cells DIM-C-pPhOCH(3) induces genes associated with metabolism, homeostasis, signal transduction, transcription, stress, transport, immune responses, growth inhibition and apoptosis. Among the most highly induced growth inhibitory and proapoptotic genes including activating transcription factor 3 (ATF3), p21, cystathionase, dual specificity phosphatase 1 and growth differentiation factor 15, RNA interference studies demonstrated that induction of all but the later gene by DIM-C-pPhOCH(3) were TR3-dependent. We also observed that DIM-C-pPhOCH(3) induced Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and induction of TRAIL was ATF3 dependent. Results of this and previous studies demonstrate that TR3 is unique among nuclear receptors since nuclear TR3 is activated or deactivated by diindolylmethane derivatives to induce different apoptotic and growth inhibitory pathways that inhibit pancreatic cancer cell and tumor growth.

Indexed as

AnimalsApoptosisBiomarkers, TumorBlotting, WesternCell Line, TumorCell NucleusCell ProliferationGene Expression ProfilingHumansImmunoenzyme TechniquesIndolesMaleMiceMice, NudeNuclear Receptor Subfamily 4, Group A, Member 1Oligonucleotide Array Sequence Analysis3,3'-diindolylmethaneBiomarkers, TumorIndolesNR4A1 protein, humanNuclear Receptor Subfamily 4, Group A, Member 1RNA, Messenger

Identifiers

PMID21362629
PMCPMC3106434
OpenAlexW2161600463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.